Chester County News and Community Website
CHESTER SPRINGS, PA — Affinity Bio Partners recently announced its expansion into India. The company states it intends on opening offices in the near future. The CRO which focuses heavily on …
Affinity Bio Partners Expands Its Operations Into India Read More
JENKINTOWN, PA — SFA Therapeutics, Inc. recently announced a new publication of their research in hepatitis B, where they are developing a drug that has the potential to become a …
SFA Therapeutics Publishes Research on Its New Approach to Treating Hepatitis B and Chronic Liver Disease Read More
A new weight loss drug has been shown to be successful in a phase 3 clinical trial. Eli Lilly and Company’s (NYSE: LLY) tirzepatide was shown to result in weight …
New Drug Achieves Weight Loss in Adults with Obesity Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration says that it recently approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in adults and pediatric patients 12 years and older …
FDA Approves First Treatment for Eosinophilic Esophagitis, a Chronic Immune Disorder Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently issued new draft guidance to industry for developing plans to enroll more participants from underrepresented racial and ethnic populations in …
FDA Takes Steps to Increase Racial and Ethnic Diversity in Clinical Trials Read More
MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company, announced the complete results from its Phase 2b clinical trial of bentracimab that were presented on April 2nd during …
PhaseBio Announces Positive Results from Phase 2b Trial for Bentracimab Read More
BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) recently reported positive results following the completion of a toxicology and pharmacokinetic study designed to support clinical trials with Epoladerm™, one of …
Virpax Reports Successful Results of Toxicology and Pharmacokinetic Study for Epoladerm Read More
WASHINGTON, D.C. — The following quote is attributed to Acting FDA Commissioner Janet Woodcock, M.D.:
FDA Takes New Steps Aimed at Advancing Development of Individualized Medicines to Treat Genetic Diseases Read More
RADNOR, PA — NRx Pharmaceuticals (Nasdaq: NRXP) announced this week that it has completed an analysis to identify clinical evidence that indicates a substantial improvement after treatment with ZYESAMI® (aviptadil) …
NRx Pharmaceuticals Identifies Significantly Higher Likelihood of Surviving and Recovering from Critical COVID-19 in ZYESAMI Read More BERWYN, PA — Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX), announced that the Investigational New Drug (IND) Application enabling studies for Envelta™ being performed under a Cooperative Research and Development Agreement (CRADA) …
Virpax to Use Envelta IND Enabling Study Results for Two Additional Indications Read More